Production (Stage)
Arrowhead Pharmaceuticals, Inc.
ARWR
$15.13
-$0.26-1.69%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.10B | 550.84M | 677.46M | 434.47M | 520.91M |
| Total Receivables | 2.37M | 2.50M | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 23.77M | 9.37M | 9.54M | 9.21M | 11.02M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 13.78M | 7.84M | 8.47M | 6.38M | 9.71M |
| Total Current Assets | 1.14B | 570.54M | 695.47M | 450.06M | 541.65M |
|
|
|||||
| Total Current Assets | 1.14B | 570.54M | 695.47M | 450.06M | 541.65M |
| Net Property, Plant & Equipment | 429.26M | 431.94M | 431.29M | 420.25M | 403.88M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 7.71M | 8.14M | 8.56M | 8.99M | 9.41M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.31M | 3.08M | 4.48M | 4.46M | 210.00K |
| Total Assets | 1.57B | 1.01B | 1.14B | 883.76M | 955.15M |
|
|
|||||
| Total Accounts Payable | 9.98M | 14.46M | 11.39M | 26.55M | 8.52M |
| Total Accrued Expenses | 94.71M | 68.10M | 80.80M | 56.79M | 43.53M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 71.78M | 8.19M | 6.34M | 6.05M | 5.29M |
| Total Finance Division Other Current Liabilities | 44.07M | 3.01M | 4.64M | 7.33M | 7.84M |
| Total Other Current Liabilities | 44.07M | 3.01M | 4.64M | 7.33M | 7.84M |
| Total Current Liabilities | 220.54M | 93.76M | 103.17M | 96.71M | 65.18M |
|
|
|||||
| Total Current Liabilities | 220.54M | 93.76M | 103.17M | 96.71M | 65.18M |
| Long-Term Debt | 561.20M | 754.57M | 734.54M | 336.03M | 280.94M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 107.53M | 109.30M | 111.03M | 112.04M | 113.63M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 889.27M | 957.62M | 948.74M | 544.79M | 459.75M |
|
|
|||||
| Common Stock & APIC | 2.11B | 1.85B | 1.81B | 1.79B | 1.77B |
| Retained Earnings | -1.43B | -1.80B | -1.63B | -1.45B | -1.28B |
| Treasury Stock & Other | 4.39M | 4.14M | 4.75M | -987.00K | -1.10M |
| Total Common Equity | 683.32M | 52.59M | 185.44M | 330.55M | 483.79M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 683.32M | 52.59M | 185.44M | 330.55M | 483.79M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 904.00K | 3.49M | 5.62M | 8.43M | 11.61M |
| Total Equity | 684.23M | 56.08M | 191.06M | 338.97M | 495.41M |
|
|
|||||